Regulatory post‐market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies

Information on rare adverse effects is often limited when a medication is initially approved for marketing. Medicines regulators use safety advisories to warn health professionals and consumers about emerging harms. This study aimed to identify characteristics and advice provided in cardiac safety a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hooimeyer, Ashleigh, Bhasale, Alice, Perry, Lucy, Fabbri, Alice, Mohammad, Annim, McEwin, Eliza, Mintzes, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652786/
https://www.ncbi.nlm.nih.gov/pubmed/33169534
http://dx.doi.org/10.1002/prp2.680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652786/
https://www.ncbi.nlm.nih.gov/pubmed/33169534
http://dx.doi.org/10.1002/prp2.680

Ejemplares similares